Skip to main
OPCH

OPCH Stock Forecast & Price Target

OPCH Analyst Ratings

Based on 9 analyst ratings
Buy
Strong Buy 33%
Buy 56%
Hold 11%
Sell 0%
Strong Sell 0%

Bulls say

Option Care Health is well positioned for growth with increased revenue and adjusted EPS expected in Q4. The company's expanded repurchase program and strong relationships with healthcare providers and payors also bode well for future success. However, a potential narrowing of networks by insurers and changes in government reimbursement, as well as potential risks with M&A and the growth of biosimilars, could pose challenges for the company's future growth and margins.

Bears say

Option Care Health is expected to see negative impacts from Stelara-related profit headwinds in 2026, as the medication will be subject to the Inflation Reduction Act and biosimilar conversions. However, the company's diverse portfolio and strong cash flows provide potential upside from capital deployment and a de-risked product portfolio. Despite raising the target multiple to 14x, a higher multiple is warranted due to minimal future downside from Stelara beyond 2026 and increased portfolio transparency, resulting in a Price Target of $38 and a Market Outperform rating.

OPCH has been analyzed by 9 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 56% recommend Buy, 11% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Option Care Health and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Option Care Health (OPCH) Forecast

Analysts have given OPCH a Buy based on their latest research and market trends.

According to 9 analysts, OPCH has a Buy consensus rating as of Apr 28, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $37.11, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $37.11, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Option Care Health (OPCH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.